Literature DB >> 16544406

Botswana: Refugees not entitled to same services as citizens.

Vanisree Trippayya.   

Abstract

Botswana, among the countries with the highest HIV/AIDS prevalence rates in the world, has been recognized internationally for its ambitious program to offer voluntary counseling and testing, prevention of mother-to-child transmission (PMTCT) and antiretroviral (ARV) treatment to all residents. Unfortunately, these policies have not been extended to the large numbers of refugees in Botswana. Botswana's Refugee Recognition and Control Act does not recognize a refugee as an ordinary resident.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16544406

Source DB:  PubMed          Journal:  HIV AIDS Policy Law Rev        ISSN: 1712-624X


  4 in total

1.  Is forced migration a barrier to treatment success? Similar HIV treatment outcomes among refugees and a surrounding host community in Kuala Lumpur, Malaysia.

Authors:  Joshua B Mendelsohn; Marian Schilperoord; Paul Spiegel; Susheela Balasundaram; Anuradha Radhakrishnan; Christopher K C Lee; Natasha Larke; Alison D Grant; Egbert Sondorp; David A Ross
Journal:  AIDS Behav       Date:  2014-02

Review 2.  HIV/AIDS health care challenges for cross-country migrants in low- and middle-income countries: a scoping review.

Authors:  Rapeepong Suphanchaimat; Angkana Sommanustweechai; Chiraporn Khitdee; Chompoonut Thaichinda; Kanang Kantamaturapoj; Pattara Leelahavarong; Pensom Jumriangrit; Thitikorn Topothai; Thunthita Wisaijohn; Weerasak Putthasri
Journal:  HIV AIDS (Auckl)       Date:  2014-02-26

3.  Maximizing the benefits of antiretroviral therapy for key affected populations.

Authors:  Ian R Grubb; Sarah W Beckham; Michel Kazatchkine; Ruth M Thomas; Eliot R Albers; Mauro Cabral; Joep Lange; Stefano Vella; Manoj Kurian; Chris Beyrer
Journal:  J Int AIDS Soc       Date:  2014-07-18       Impact factor: 5.396

4.  Antiretroviral therapy for refugees and internally displaced persons: a call for equity.

Authors:  Joshua B Mendelsohn; Paul Spiegel; Marian Schilperoord; Nadine Cornier; David A Ross
Journal:  PLoS Med       Date:  2014-06-10       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.